4//SEC Filing
FUERST THOMAS RICHARD 4
Accession 0001144204-10-018996
CIK 0001326190other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 9:12 PM ET
Size
6.0 KB
Accession
0001144204-10-018996
Insider Transaction Report
Form 4
FUERST THOMAS RICHARD
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2010-04-05+350,000→ 350,000 totalExercise: $1.69From: 2010-04-05Exp: 2020-04-05→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]On April 5, 2010, the date such options were granted, the closing price of the Issuer's Common Stock on the NYSE Amex was $1.69 per share.
- [F2]On April 5, 2010, the date such options were granted, 50,000 stock options vested immediately. The remaining stock options vest over a 4 year period with 75,000 stock options each vesting on the first, second, third and fourth anniversaries of the grant date.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001488331
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 9:12 PM ET
- Size
- 6.0 KB